FULZOS 250 MG 5 ML INJ
Prescription Required
Couldn't load pickup availability

- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Fulzos 250mg Injection contains fulvestrant, an oestrogen-receptor antagonist that blocks and degrades oestrogen receptors in hormone-sensitive breast-cancer cells.
Uses
Fulzos 250mg/5ml Injection is used for the treatment of hormone receptor-positive, locally advanced or metastatic breast cancer in postmenopausal women.
- Hormone receptor-positive breast cancer.
- Locally advanced breast cancer.
- Metastatic breast cancer.
- Used alone or with other targeted anticancer medicines.
Storage
- Store refrigerated at 2°C–8°C in the original packaging.
- Protect from light.
- Do not freeze.
Safety Information
- Administer as a deep intramuscular injection by a healthcare professional.
- Inform your doctor about bleeding disorders, anticoagulant use, liver disease, pregnancy or breastfeeding.
Possible Side Effects
Possible side effects may include:
- Injection site pain
- Hot flushes
- Nausea
- Fatigue
- Headache
- Joint pain
- Muscle pain
- Elevated liver enzymes
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Fulzos is a prescription anticancer medicine.
It should only be administered under the supervision of a qualified oncologist.